FMG133M

首页 > 组织芯片 > 乳腺 > FMG133M

类型
- 冰冻组织
- 石蜡组织
种类
器官
- 乳腺
- 卵巢
- 口腔
- 外阴
- 多器官
- 大鼠
- 头颈部
- 子宫
- 子宫内膜
- 小鼠
- 心脏
- 恶性黑色素瘤
- 狗
- 猴子-恒河猴（正常）-RsFPT
- 猴子-食蟹猴（正常）-CyFPT
- 皮肤
- 直肠
- 睾丸
- 结肠
- 肝脏
- 肠道
- 肺
- 肾上腺
- 肾脏
- 胃
- 胆囊和胆管
- 胎儿
- 胰腺
- 胸腺
- 脾脏
- 膀胱
- 软组织
- 输卵管
- 阑尾
- 阴茎
- 食管胃交界处
- 食道
- 骨_软骨
- 骨髓
类型/疾病
例数
- 小于25
- 26~70
- 71~100
- 101~200
- 201~300
- 大于301
点数
- 小于25
- 26~70
- 71~100
- 101~200
- 201~300
- 大于301

点数:

133

例数:

62

点样直径（mm）:

1

厚度（µm）:

5

行数:

10

列数:

14

组织阵列类型:

FFPE

种属:

Human

FMG133M

加入收藏

描述: 三阴乳腺癌组织芯片，62例/133点

详情: 三阴乳腺癌组织微阵列芯片，包含61例乳腺癌及匹配淋巴结转移癌，11例乳腺组织（其中10例与癌匹配），一块一点

应用: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

备注

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

说明书列表
重复病例
下载说明书

图表:

Breast

Metastasis(IIIC)
Metastasis(IIZA)
Metastasis(IIIB)
Metastasis(IIA)
Metastasis(IIIA)
Metastasis(IIB)
Metastasis(IB)
Malignant(IB)
Malignant(IIA)
Malignant(IIB)
Malignant(IIIA)
Malignant(IIIB)
Malignant(IIIC)
AT(*)

组织芯片
FMG133M

	1	2	3	4	5	6	7	8	9	10	11	12	13	14
A	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
B	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
C	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
D	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
E	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
F	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
G	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
H	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
I	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
J	Bre	Bre	Bre	Bre	Bre	Bre	Bre

FMG133M

年龄:
性别:
器官/解剖部位:
病理诊断:
等级:
分期:
阶段:
组织ID.:
类型:

POS	No.	Age	Sex	Organ/Anatomic Site	Pathology diagnosis	Grade	TNM	Stage	Type	Ki-67	ER	PR	Her-2
A1	1	51	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Malignant	0.2	-	-	-
A2	2	51	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Metastasis	0.03	-	-	-
A3	3	37	F	Breast	Invasive carcinoma of no special type	*	T1cN2aM0	IIIA	Malignant	0.4	-	-	-
A4	4	37	F	Breast	Invasive carcinoma of no special type	*	T1cN2aM0	IIIA	Metastasis	0.02	-	-	-
A5	5	45	F	Breast	Invasive carcinoma of no special type	*	T2N1M0	IIB	Malignant	0.65	-	-	-
A6	6	45	F	Breast	Invasive carcinoma of no special type	*	T2NlM0	IIB	Metastasis	0.85	-	-	-
A7	7	52	F	Breast	Invasive carcinoma of no special type	*	T3NlM0	IIIA	Malignant	0.65	-	-	-
A8	8	52	F	Breast	Invasive carcinoma of no special type	*	T3N1M0	IIIA	Metastasis	0.55	-	-	-
A9	9	57	F	Breast	Invasive carcinoma of no special type	*	T3N2aM0	IIIA	Malignant	0.8	-	-	-
A10	10	57	F	Breast	Invasive carcinoma of no special type	*	T3N2aM0	IIIA	Metastasis	0.8	-	-	-
A11	11	44	F	Breast	Invasive carcinoma of no special type	*	T2N1aM0	IIB	Malignant	0.35	-	-	-
A12	12	44	F	Breast	Invasive carcinoma of no special type	*	T2N1aM0	IIB	Metastasis	0.35	-	-	-
A13	13	43	F	Breast	Invasive carcinoma of no special type	*	T1aN2aM0	IIIA	Malignant	0.05	-	-	-
A14	14	43	F	Breast	Invasive carcinoma of no special type	*	T1aN2aM0	IIIA	Metastasis	0.05	-	-	-
B1	15	35	F	Breast	Invasive carcinoma of no special type	*	T1bN1miM0	IB	Malignant	0.85	-	-	-
B2	16	35	F	Breast	Invasive carcinoma of no special type	*	T1bN1miM0	IB	Metastasis	0.35	-	-	-
B3	17	47	F	Breast	Invasive carcinoma of no special type	*	T2NlM0	IIB	Malignant	0.45	-	-	-
B4	18	47	F	Breast	Invasive carcinoma of no special type	*	T2N1M0	IIB	Metastasis	/	-	-	-
B5	19	67	F	Breast	Invasive carcinoma of no special type	*	T1N1M0	IIA	Malignant	0.2	-	-	1+
B6	20	67	F	Breast	Invasive carcinoma of no special type	*	T1N1M0	IIA	Metastasis	/	*	*	*
B7	21	49	F	Breast	Invasive carcinoma of no special type	*	T3N2aM0	IIIA	Malignant	0.75	-	-	-
B8	22	49	F	Breast	Invasive carcinoma of no special type	*	T3N2aM0	IIIA	Metastasis	0.35	-	-	-
B9	23	46	F	Breast	Invasive carcinoma of no special type	*	T2N2aM0	IIIA	Malignant	0.3	-	-	-
B10	24	46	F	Breast	Invasive carcinoma of no special type	*	T2N2aM0	IIIA	Metastasis	0.05	-	-	-/+
B11	25	64	F	Breast	Invasive carcinoma of no special type	*	T2N1M0	IIB	Malignant	0.15	-(N+)	-(N+)	-
B12	26	64	F	Breast	Invasive carcinoma of no special type	*	T2N1M0	IIB	Metastasis	/	-	-	-
B13	27	46	F	Breast	Invasive carcinoma of no special type	*	T1bN1M0	IIA	Malignant	＜2%	-	-	-
B14	28	46	F	Breast	Invasive carcinoma of no special type	*	T1bN1M0	IIA	Metastasis	＜2%	-	-	-
C1	29	54	F	Breast	Invasive carcinoma of no special type	*	T2N2aM0	IIIA	Malignant	0.08	-	-	-
C2	30	54	F	Breast	Invasive carcinoma of no special type	*	T2N2aM0	IIIA	Metastasis	0.3	-	-	-
C3	31	38	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Malignant	0.5	-	-	-
C4	32	38	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Metastasis	0.8	-	-	-
C5	33	47	F	Breast	Invasive carcinoma of no special type	*	T2N1M0	IIB	Malignant	＜5%	-	-	-
C6	34	47	F	Breast	Invasive carcinoma of no special type	*	T2N1M0	IIB	Metastasis	/	-	-	-
C7	35	63	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Malignant	＜5%	-	-	-
C8	36	63	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Metastasis	＜5%	-	-	-
C9	37	33	F	Breast	Invasive carcinoma of no special type	*	T2N1M0	IIB	Malignant	0.35	-	-	-
C10	38	33	F	Breast	Invasive carcinoma of no special type	*	T2N1M0	IIB	Metastasis	0.6	-	-	-
C11	39	39	F	Breast	Invasive carcinoma of no special type	*	T2N1M0	IIB	Malignant	0.7	-	-	-
C12	40	39	F	Breast	Invasive carcinoma of no special type	*	T2N1M0	IIB	Metastasis	0.35	-	-	-
C13	41	41	F	Breast	Invasive carcinoma of no special type	*	T1cN1miM0	IB	Malignant	0.3	-	-	-
C14	42	41	F	Breast	Invasive carcinoma of no special type	*	T1cN1miM0	IB	Metastasis	0.5	-	-	-
D1	43	66	F	Breast	Invasive carcinoma of no special type	*	T2N1M0	IIB	Malignant	＜5%	-	-	-
D2	44	66	F	Breast	Invasive carcinoma of no special type	*	T2N1M0	IIB	Metastasis	＜5%	*	*	*
D3	45	39	F	Breast	Invasive carcinoma of no special type	*	T4aN3cM0	IIIC	Malignant	0.4	-	-	-
D4	46	39	F	Breast	Invasive carcinoma of no special type	*	T4aN3cM0	IIIC	Metastasis	0.4	-	-	-
D5	47	51	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Malignant	＜5%	-	-	-
D6	48	51	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Metastasis	＜5%	-	-	-
D7	49	39	F	Breast	Invasive carcinoma of no special type	*	T1bN1M0	IIA	Malignant	＜5%	-	-	-
D8	50	39	F	Breast	Invasive carcinoma of no special type	*	T1bN1M0	IIA	Metastasis	0.2	-	-	-
D9	51	55	F	Breast	Invasive carcinoma of no special type	*	T2N2aM0	IIIA	Malignant	0.05	-	-	-
D10	52	55	F	Breast	Invasive carcinoma of no special type	*	T2N2aM0	IIIA	Metastasis	0.1	-	-	-
D11	53	66	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Malignant	＜5%	-(N+)	-	-
D12	54	66	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Metastasis	0.8	-	-	-
D13	55	53	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Malignant	＜5%	-(N+)	-	-
D14	56	53	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Metastasis	＜5%	-	-	-
E1	57	50	F	Breast	Invasive carcinoma of no special type	*	T2N1M0	IIB	Malignant	0.1	-	-	-
E2	58	50	F	Breast	Invasive carcinoma of no special type	*	T2N1M0	IIB	Metastasis	＜5%	-	-	-
E3	59	58	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Malignant	0.25	-	-	-
E4	60	58	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Metastasis	＜5%	-	-	-
E5	61	57	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Malignant	＜5%	-	-	-
E6	62	57	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Metastasis	＜5%	-	-	*
E7	63	23	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Malignant	0.1	-(N+)	-	-
E8	64	23	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Metastasis	/	-	-	-
E9	65	/	F	Breast	Invasive carcinoma of no special type	*	T2N1M0	IIB	Malignant	0.4	-	-	-
E10	66	/	F	Breast	Invasive carcinoma of no special type	*	T2N1M0	IIB	Metastasis	0.1	+30%	+30%	1+
E11	67	69	F	Breast	Invasive carcinoma of no special type	*	T2N1M0	IIB	Malignant	0.35	-	-	-
E12	68	69	F	Breast	Invasive carcinoma of no special type	*	T2N1M0	IIB	Metastasis	0.35	-	-	-
E13	69	48	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Malignant	0.15	-	-	-
E14	70	48	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Metastasis	＜5%	+20%	-	*
F1	71	38	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Malignant	0.5	-	-	-
F2	72	38	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIZA	Metastasis	0.15	-	-	-
F3	73	32	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Malignant	0.25	+30%	+30%	-
F4	74	32	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Metastasis	＜5%	-	-	-
F5	75	/	F	Breast	Invasive carcinoma of no special type	*	T4cN2aM0	IIIB	Malignant	0.8	-	-	-
F6	76	/	F	Breast	Invasive carcinoma of no special type	*	T4cN2aM0	IIIB	Metastasis	0.15	-	-	-
F7	77	59	F	Breast	Invasive carcinoma of no special type	*	T2N1M0	IIB	Malignant	＜5%	-	-	-
F8	78	59	F	Breast	Invasive carcinoma of no special type	*	T2N1M0	IIB	Metastasis	＜5%	-	-	-
F9	79	48	F	Breast	Invasive carcinoma of no special type	*	T2N2aM0	IIIA	Malignant	0.15	-	-	-
F10	80	48	F	Breast	Invasive carcinoma of no special type	*	T2N2aM0	IIIA	Metastasis	0.15	-	-	-/+
F11	81	/	F	Breast	Invasive carcinoma of no special type	*	T2N2aM0	IIIA	Malignant	0.2	-	-	-
F12	82	/	F	Breast	Invasive carcinoma of no special type	*	T2N2aM0	IIIA	Metastasis	0.3	-	-	-
F13	83	46	F	Breast	Invasive carcinoma of no special type	*	T1cN3cM0	IIIC	Malignant	＜5%	-	-	-
F14	84	46	F	Breast	Invasive carcinoma of no special type	*	T1cN3cM0	IIIC	Metastasis	0.45	-	-	-
G1	85	58	F	Breast	Invasive carcinoma of no special type	*	T2N2aM0	IIIA	Malignant	0.8	-	-	-
G2	86	58	F	Breast	Invasive carcinoma of no special type	*	T2N2aM0	IIIA	Metastasis	0.8	-	-	-
G3	87	59	F	Breast	Invasive carcinoma of no special type	*	T1bN1M0	IIA	Malignant	＜5%	-	-	-/+
G4	88	59	F	Breast	Invasive carcinoma of no special type	*	T1bN1M0	IIA	Metastasis	0.55	-	-	-
G5	89	74	F	Breast	Medullary carcinoma	*	T2N1M0	IIB	Malignant	0.7	-	-	-
G6	90	74	F	Breast	Medullary carcinoma	*	T2N1M0	IIB	Metastasis	0.55	-	-	-
G7	91	39	F	Breast	Metaplastic carcinoma	*	T2N1M0	IIB	Malignant	0.85	-	-	-
G8	92	39	F	Breast	Metaplastic carcinoma	*	T2N1M0	IIB	Metastasis	0.2	-	-	-/+
G9	93	53	F	Breast	Invasive carcinoma of no special type	*	T2N1M0	IIB	Malignant	0.55	-	-	-
G10	94	53	F	Breast	Invasive carcinoma of no special type	*	T2N1M0	IIB	Metastasis	0.55	-	-	-
G11	95	39	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Malignant	0.2	-	-	-
G12	96	39	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Metastasis	0.4	-	-	-
G13	97	49	F	Breast	Invasive carcinoma of no special type	*	T2N1M0	IIB	Malignant	0.1	-	-	/
G14	98	49	F	Breast	Invasive carcinoma of no special type	*	T2N1M0	IIB	Metastasis	0.45	-	-	-
H1	99	59	F	Breast	Invasive carcinoma of no special type	*	T2N2aM0	IIIA	Malignant	＜5%	-	-	-
H2	100	59	F	Breast	Invasive carcinoma of no special type	*	T2N2aM0	IIIA	Metastasis	0.55	-	-	-
H3	101	42	F	Breast	Multiforme lobular carcinoma	*	T3T2aM0	IIIA	Malignant	＜5%	-	-	*
H4	102	42	F	Breast	Multiforme lobular carcinoma	*	T3N2aM0	IIIA	Metastasis	/	-	-	-
H5	103	44	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Malignant	0.25	-	-	-
H6	104	44	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Metastasis	/	-	-	-
H7	105	72	F	Breast	Invasive carcinoma of no special type	*	T3N1M0	IIIA	Malignant	0.15	-	-	-
H8	106	72	F	Breast	Invasive carcinoma of no special type	*	T3N1M0	IIIA	Metastasis	0.15	-	-	-
H9	107	45	F	Breast	Invasive carcinoma of no special type	*	T3N2aM0	IIIA	Malignant	0.15	-	-	-
H10	108	45	F	Breast	Invasive carcinoma of no special type	*	T3N2aM0	IIIA	Metastasis	0.15	-	-	-
H11	109	68	F	Breast	Invasive carcinoma of no special type and Lobular carcinoma	*	T2N2aM0	IIIA	Malignant	0.8	-	-	-
H12	110	68	F	Breast	Invasive carcinoma of no special type and Lobular carcinoma	*	T2N2aM0	IIIA	Metastasis	0.8	-	-	-
H13	111	68	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Malignant	＜5%	-	-	*
H14	112	68	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Metastasis	＜5%	-	-	1+
I1	113	48	F	Breast	Invasive carcinoma of no special type	*	T1bN1M0	IIA	Malignant	0.9	-	-	-
I2	114	48	F	Breast	Invasive carcinoma of no special type	*	T1bN1M0	IIA	Metastasis	0.4	-	-	-
I3	115	43	F	Breast	Invasive carcinoma of no special type	*	T2N1M0	IIB	Malignant	0.3	-	-	-
I4	116	43	F	Breast	Invasive carcinoma of no special type	*	T2N1M0	IIB	Metastasis	/	+10%	-	-
I5	117	47	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Malignant	0.45	-	-	-
I6	118	47	F	Breast	Invasive carcinoma of no special type	*	T1cN1M0	IIA	Metastasis	＜5%	-	-	-
I7	119	40	F	Breast	Invasive carcinoma of no special type	*	T1bN1M0	IIA	Malignant	0.6	-	-(N+)	-
I8	120	40	F	Breast	Invasive carcinoma of no special type	*	T1bN1M0	IIA	Metastasis	0.5	-	-	-
I9	121	50	F	Breast	Invasive carcinoma of no special type	*	T1bN1M0	IIA	Malignant	0.3	-	-	-
I10	122	50	F	Breast	Invasive carcinoma of no special type	*	T1bN1M0	IIA	Metastasis	N ＜5%	-	-	-
I11	123	50	F	Breast	Cancer adjacent breast tissue	*	*	*	AT	N ＜5%	-	-	N-
I12	124	51	F	Breast	Cancer adjacent breast tissue	*	*	*	AT	N ＜5%	N+	*	N-
I13	125	39	F	Breast	Cancer adjacent breast tissue	*	*	*	AT	N ＜5%	N+	N+	N-
I14	126	55	F	Breast	Cancer adjacent breast tissue	*	*	*	AT	N ＜5%	N+	N-	N-
J1	127	66	F	Breast	Cancer adjacent breast tissue	*	*	*	AT	N ＜5%	N+	N+	N-
J2	128	53	F	Breast	Cancer adjacent breast tissue	*	*	*	AT	N ＜5%	N+	N-	*
J3	129	50	F	Breast	Cancer adjacent breast tissue	*	*	*	AT	N ＜5%	N+	N++	N-
J4	130	58	F	Breast	Cancer adjacent breast tissue	*	*	*	AT	N ＜5%	N+	-	-/+
J5	131	57	F	Breast	Cancer adjacent breast tissue	*	*	*	AT	N ＜5%	N+	N-	N-
J6	132	23	F	Breast	Cancer adjacent breast tissue	*	*	*	AT	N ＜5%	N+	N-	N-
J7	133	45	F	Breast	Cancer adjacent breast tissue	*	*	*	AT	N ＜5%	N+	N-	N-

查找与该芯片存在重复病例的芯片:

如需了解产品规格方面的任何问题，请联系我们

	1	2	3	4	5	6	7	8	9	10	11	12	13	14
A	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
B	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
C	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
D	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
E	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
F	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
G	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
H	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
I	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
J	Bre	Bre	Bre	Bre	Bre	Bre	Bre

	1	2	3	4	5	6	7	8	9	10	11	12	13	14
A	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
B	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
C	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
D	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
E	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
F	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
G	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
H	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
I	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
J	Bre	Bre	Bre	Bre	Bre	Bre	Bre

	1	2	3	4	5	6	7	8	9	10	11	12	13	14
A	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
B	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
C	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
D	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
E	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
F	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
G	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
H	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
I	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre	Bre
J	Bre	Bre	Bre	Bre	Bre	Bre	Bre